Alturaiki, Wael, Alkadi, Haitham, Alamri, Saad, Awadalla, Maaweya E, Alfaez, Abdulkarim, Mubarak, Ayman, Alanazi, Mona Awad, Alenzi, Faris Q, Flanagan, Brian F and Alosaimi, Bandar
(2023)
Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severity.
HELIYON, 9 (1).
e12653-.
ISSN 2405-8440, 2405-8440
|
PDF
Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and.pdf - Open Access published version Download (1MB) | Preview |
Abstract
The recent identification of the involvement of the immune system response in the severity and mortality of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection highlights the importance of cytokines and chemokines as important factors in the clinical outcomes of COVID-19. However, the impact and roles of the BAFF/APRIL cytokine system, homeostatic chemokines (CXCL12, CXCL13, CCL19, and CCL21), as well as Toll-like receptor (TLR)-3/4 in COVID-19, have not been investigated. We sought to assess the expression levels and roles of TLR3/4, BAFF, APRIL, IFN-β, homeostatic chemokines (CXCL12, CXCL13, CCL19, and CCL21), SARS-CoV-2 IgG and IgM antibodies in patients with critical (ICU) and non-ICU (mild) COVID-19 and their association with mortality and disease severity. Significant high levels of TLR-4 mRNA, IFN-β, APRIL, CXCL13, and IgM and IgG antibodies were observed in ICU patients with severe COVID-19 compared to non-ICU COVID-19 patients and healthy controls. On the other hand, BAFF and CCL21 expression were significantly upregulated in non-ICU patients with COVID-19 compared with that in critical COVID-19 patients. The two groups did not differ in TLR-3, CXCL12, and CCL19 levels. Our findings show high expression levels of some inflammatory chemokines in ICU patients with COVID-19. These findings highlight the potential utility of chemokine antagonists as an immune-based treatment for the severe form of COVID-19. We also believe that selective targeting of TLR/spike protein interactions might lead to the development of a new COVID-19 therapy.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Toll -like receptors, Cytokines, Homeostatic chemokines, SARS-CoV-2, COVID-19 severity |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 17 May 2023 13:13 |
| Last Modified: | 06 Dec 2024 20:38 |
| DOI: | 10.1016/j.heliyon.2022.e12653 |
| Open Access URL: | https://doi.org/10.1016/j.heliyon.2022.e12653 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3170429 |
Altmetric
Altmetric
